# Adagene Inc.: financial statements, quarterly

ADAG · Nasdaq · CIK 1818838 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adag.md) · [Financials](/companies/adag/financials.md) · [Filings](/companies/adag/filings.md) · [Insiders](/companies/adag/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/adag/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [92.5](/filings/0001104659-21-055911.md) | [75.2](/filings/0001104659-22-050329.md) | [174](/filings/0001104659-23-052043.md) | [144](/filings/0001104659-24-041109.md) | [110](/filings/0001410578-25-000419.md) | [85.2](/filings/0001104659-26-038612.md) | [74.5](/filings/0001104659-26-038612.md) |
| Current assets | $m | not reported | not reported | [104](/filings/0001104659-21-055911.md) | [79.1](/filings/0001104659-22-050329.md) | [186](/filings/0001104659-23-052043.md) | [149](/filings/0001104659-24-041109.md) | [113](/filings/0001410578-25-000419.md) | [87.8](/filings/0001104659-26-038612.md) | [77.4](/filings/0001104659-26-038612.md) |
| Total assets | $m | not reported | not reported | [106](/filings/0001104659-21-055911.md) | [84.3](/filings/0001104659-22-050329.md) | [190](/filings/0001104659-23-052043.md) | [152](/filings/0001104659-24-041109.md) | [116](/filings/0001410578-25-000419.md) | [89.3](/filings/0001104659-26-038612.md) | [78.3](/filings/0001104659-26-038612.md) |
| Current liabilities | $m | not reported | not reported | [7.2](/filings/0001104659-21-055911.md) | [16.1](/filings/0001104659-22-050329.md) | [29.8](/filings/0001104659-23-052043.md) | [55.1](/filings/0001104659-24-041109.md) | [31.5](/filings/0001410578-25-000419.md) | [38.2](/filings/0001104659-26-038612.md) | [25.2](/filings/0001104659-26-038612.md) |
| Total liabilities | $m | not reported | not reported | [8.7](/filings/0001104659-21-055911.md) | [19.2](/filings/0001104659-22-050329.md) | [33.0](/filings/0001104659-23-052043.md) | [69.3](/filings/0001104659-24-041109.md) | [45.2](/filings/0001410578-25-000419.md) | [38.7](/filings/0001104659-26-038612.md) | [26.4](/filings/0001104659-26-038612.md) |
| Long-term debt | $m | not reported | not reported | [1.5](/filings/0001104659-21-055911.md) | [3.0](/filings/0001104659-22-050329.md) | [3.0](/filings/0001104659-23-052043.md) | [14.1](/filings/0001104659-24-041109.md) | [13.5](/filings/0001410578-25-000419.md) | [0.4](/filings/0001104659-26-038612.md) | [1.1](/filings/0001104659-26-038612.md) |
| Current portion of debt | $m | not reported | not reported | [0.3](/filings/0001104659-21-055911.md) | [1.2](/filings/0001104659-22-050329.md) | [1.4](/filings/0001104659-23-052043.md) | [2.9](/filings/0001104659-24-041109.md) | [4.2](/filings/0001410578-25-000419.md) | [12.9](/filings/0001104659-26-038612.md) | [0.7](/filings/0001104659-26-038612.md) |
| Shareholders' equity | $m | [(25.7)](/filings/0001104659-21-055911.md) | [(41.0)](/filings/0001104659-22-050329.md) | [(57.0)](/filings/0001104659-23-052043.md) | [(89.4)](/filings/0001104659-24-041109.md) | [157](/filings/0001410578-25-000419.md) | [83.1](/filings/0001104659-26-038612.md) | [70.6](/filings/0001104659-26-038612.md) | [50.5](/filings/0001104659-26-038612.md) | [35.3](/filings/0001104659-26-038612.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 59,231,993 at 2025-12-31, from the cover of the [20-F filed 2026-04-01](/filings/0001104659-26-038612.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.